Financials

News Ideas Discussions Technicals Forecast Seasonals

2126 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to JW (CAYMAN) THERAPEUTICS CO. LTD operating, investing, and financing activities

2126 free cash flow for H1 24 is -212.42 M HKD. For 2023, 2126 free cash flow was -465.23 M HKD and operating cash flow was -451.52 M HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—